Jim Simons Renaissance Technologies
Jim Simons is the founder of Renaissance Technologies, one of the most successful quantitative hedge funds in the world. Before his career in finance, he served as a mathematics professor and made significant contributions to differential geometry. Simons applied his analytical expertise to develop sophisticated, algorithm-driven trading strategies, earning consistently high returns for investors.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Eli Lilly
LLY
|
+$671M |
| 2 |
McDonald's
MCD
|
+$636M |
| 3 |
TSMC
TSM
|
+$515M |
| 4 |
NVO
Novo Nordisk
NVO
|
+$465M |
| 5 |
Colgate-Palmolive
CL
|
+$458M |
Top Sells
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 14.45% |
| 2 | Healthcare | 11.94% |
| 3 | Consumer Discretionary | 11.58% |
| 4 | Consumer Staples | 10.68% |
| 5 | Financials | 9.61% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
126
Urban Outfitters
URBN
$6.8B
| $62.2M | 0.16% |
+1,545,400
| New | +$63.8M |
|
127
Bio-Techne
TECH
$11.2B
| $62.1M | 0.16% |
+3,593,600
| New | +$59.7M |
|
128
Myriad Genetics
MYGN
$308M
| $61.2M | 0.16% |
+2,279,374
| New | +$66.1M |
|
|
CHS
129
DELISTED
Chicos FAS, Inc.
CHS
| $61.1M | 0.16% |
+3,579,300
| New | +$63.9M |
|
|
RDS.B
130
DELISTED
Royal Dutch Shell PLC ADS Class B
RDS.B
| $60.8M | 0.16% |
+916,927
| New | +$62.6M |
|
|
SWI
131
DELISTED
SOLARWINDS INC COM STK (DE)
SWI
| $60.6M | 0.16% |
+1,562,500
| New | +$71.6M |
|
132
PVH
PVH
$3.91B
| $60.4M | 0.16% |
+483,270
| New | +$55.4M |
|
133
Costco
COST
$419B
| $60M | 0.16% |
+542,500
| New | +$59.3M |
|
|
QVCGA
134
DELISTED
QVC Group Inc Series A
QVCGA
| $59.7M | 0.16% |
+63,212
| New | +$57.1M |
|
135
Ralph Lauren
RL
$23.7B
| $59.3M | 0.16% |
+341,500
| New | +$60.1M |
|
|
NTT
136
DELISTED
Nippon Telegraph & Telephone
NTT
| $59.2M | 0.16% |
+2,274,200
| New | +$56.4M |
|
137
Lear
LEA
$8.12B
| $59.1M | 0.15% |
+976,900
| New | +$56.4M |
|
138
Altria Group
MO
$109B
| $58.4M | 0.15% |
+1,668,000
| New | +$59.9M |
|
139
Gartner
IT
$11.8B
| $57.8M | 0.15% |
+1,013,500
| New | +$57.5M |
|
|
WCRX
140
DELISTED
WARNER CHILCOTT PLC ORD SHS CL A (IRL)
WCRX
| $57.6M | 0.15% |
+2,893,400
| New | +$49M |
|
|
SFD
141
DELISTED
SMITHFIELD FOODS,INC
SFD
| $57M | 0.15% |
+1,740,062
| New | +$49.3M |
|
142
Brinker International
EAT
$9.49B
| $56.7M | 0.15% |
+1,437,400
| New | +$56.7M |
|
|
SNTS
143
DELISTED
SANTARUS INC
SNTS
| $56.5M | 0.15% |
+2,684,843
| New | +$54M |
|
|
MIC
144
DELISTED
Macquarie Infrastructure Holdings, LLC
MIC
| $56.5M | 0.15% |
+1,056,700
| New | +$58M |
|
145
NiSource
NI
$20.1B
| $56.3M | 0.15% |
+5,005,252
| New | +$57.9M |
|
|
EA
146
DELISTED
Electronic Arts
EA
| $56.3M | 0.15% |
+2,449,364
| New | +$49.9M |
|
|
BT
147
DELISTED
BT Group plc (ADR)
BT
| $56.2M | 0.15% |
+2,393,000
| New | +$54.1M |
|
|
HES
148
DELISTED
Hess
HES
| $55.8M | 0.15% |
+838,963
| New | +$58.1M |
|
|
MGLN
149
DELISTED
Magellan Health Services, Inc.
MGLN
| $55.1M | 0.14% |
+982,499
| New | +$51.5M |
|
150
Omega Healthcare
OHI
$13.8B
| $54.9M | 0.14% |
+1,769,800
| New | +$58.2M |
|
Similar funds
Jim Simons's Q2 2013 Portfolio in Review
Q2 2013 is the first quarter with a 13F filing on record for Jim Simons, which disclosed 2,756 positions worth $38.1B. Its ten largest holdings account for 11% of the portfolio.
Its largest position is Eli Lilly: 12,326,205 shares worth $605M.
By sector, the portfolio is most concentrated in Technology at 14% of assets, followed by Healthcare and Consumer Discretionary.
- Jim Simons's largest Q2 2013 buy was Eli Lilly: 12,326,205 shares worth $605M.
- Jim Simons's ten largest holdings make up 11% of its $38.1B portfolio in Q2 2013.
- Jim Simons disclosed 2,756 positions in Q2 2013, its first 13F filing on record.
Based on Renaissance Technologies's 13F filing for Q2 2013, filed 12 Aug 2013.